The Society for Maternal-Fetal Medicine (SMFM) Coding Committee; Robert Rossi, MD Katherine Kohari, MD Barbra Fisher, MD, PhD and Betzaida Martinez CPC, CPMA, COBGC, CPPM Background Multiple societies (AIUM, SMFM, ACOG, ACOOG, SDMS, SFP, and FHS) recommend performing a detailed fetal... Continue Reading
News
Journalists working on stories related to high-risk pregnancies or the Society for Maternal-Fetal Medicine can contact Greg Phillips, Director of Communications, at press@smfm.org for referrals to MFM experts and to request additional information. The press office is open Monday through Friday from 9:00 AM to 5:00 PM ET.
By Brian K. Iriye, MD; Vanita D. Jain, MD; and Anthony C. Sciscione, DO What is DFTU and Why Is It Important? The Detailed First-Trimester Ultrasound (DFTU) is a high-resolution scan performed between weeks 12 and 13 of pregnancy to detect fetal structural anomalies.1 It is indicated for... Continue Reading
As experts in high-risk pregnancies, the Society for Maternal-Fetal Medicine (SMFM) and its members are alarmed by the unsubstantiated and inaccurate claims made by FDA panelists concerning maternal depression and the use of SSRI antidepressants during pregnancy. Continue Reading
AAP, ACP, APHA, IDSA, MPHA, SMFM, and a pregnant physician, filed suit in the U.S. District Court for the District of Massachusetts to defend vaccine policy, and to put an end to the Secretary’s assault on science, public health and evidence-based medicine. Continue Reading
The Society for Maternal-Fetal Medicine (SMFM) is deeply disappointed in today’s final vote by the House of Representatives resulting in the passage of H.R. 1. The deep cuts to the Medicaid program contained in this legislation jeopardize the insurance coverage millions of... Continue Reading
SMFM urges members of the House of Representatives to reject H.R. 1 in its current form and, instead, pursue legislation that preserves and expands access to high-quality pregnancy care for all Americans. Continue Reading
As the experts in high-risk pregnancy, the Society for Maternal-Fetal Medicine (SMFM) strongly disagrees with the changes that were implemented in the proceedings of the June 2025 Advisory Committee on Immunization Practices (ACIP) meeting. Continue Reading
The Society for Maternal-Fetal Medicine (SMFM) reaffirms its support for policies that allow maternal-fetal medicine physicians and other clinicians to provide evidence-based, medically appropriate treatment to their patients. Continue Reading
By Kristen A. Cagino, MD As physicians, we recognize that medical practice is built on a foundation of research. Discovering new therapies, navigating a global pandemic, and identifying the safest, evidence-based management strategy for complex conditions all rely on rigorous, well-designed... Continue Reading
SMFM recommends that each state in the US have an active maternal mortality review committee (MMRC) and calls for each to meet a list of nine minimum standards. Continue Reading
As the experts in high-risk pregnancy, the Society for Maternal-Fetal Medicine (SMFM) strongly reaffirms its recommendation that pregnant patients receive the COVID-19 vaccine. Pregnancy increases the risk of developing severe illness compared with nonpregnant patients. Maternal immunization... Continue Reading
When I was a medical student, the disease process of preeclampsia was one of the things that sparked my interest in the field of obstetrics. Today, I am passionate about teaching patients and their families about preeclampsia because it is one of the most common conditions I manage. What Is... Continue Reading